Gossamer Bio, Inc. Common Stock

GOSS XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

47M

Short interest (May 15)

17.4%

Net Short (Jun 03 ): 0.7%

Borrow Fee

8.38%

↑ 573.9%

Available Shares

400K

↓ 76.3%

Price Chart

Company Overview

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001728117

Asset Type: CS

Market Data

Market Cap: $46,986,195

Employees: 162

Status: Active

Short Interest

Current Borrow Fee 8.38%

Range: 5.16% - 9.64%

Available Shares 400K

Range: 100K - 1.9M

Recent Changes

Fee Change: ↑ 63.0%

Available Change: ↑ 88.5%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime